Emcure Pharmaceuticals Limited
The current stock price of Emcure Pharmaceuticals Limited is ₹1,006.65, with a target price range between ₹956.32 and ₹1,056.98. The stock has experienced a price change of ₹6.60 (0.66%), reflecting recent market volatility.
Today's opening price was ₹1,000.15, while the previous close stood at ₹1,000.05.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Emcure Pharmaceuticals Limited Price Chart
Emcure Pharmaceuticals Limited Pre Open Market Overview: 21-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1000.15
- Previous Close Price: 1000.05
- Change: 0.10%
- Total Traded Volume: 607
- Total Buy Quantity: 2,252
- Total Sell Quantity: 3,030
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 998.05 | 2.00 | 0.00 |
| 999.25 | 5.00 | 0.00 |
| 1,000.00 | 15.00 | 0.00 |
| 1,000.05 | 246.00 | 0.00 |
| 1,000.15 | 136.00 | 0.00 |
| 1,003.00 | 0.00 | 55.00 |
| 1,008.00 | 0.00 | 50.00 |
| 1,011.00 | 0.00 | 14.00 |
| 1,011.90 | 0.00 | 50.00 |
| 1,013.00 | 0.00 | 50.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 1,006.20 | 1 | 1,007.40 | 9 |
| 1,006.15 | 1 | 1,007.45 | 16 |
| 1,006.00 | 4 | 1,007.50 | 17 |
| 1,005.85 | 7 | 1,007.70 | 8 |
| 1,005.60 | 10 | 1,007.75 | 1 |
Shareholding Patterns of Emcure Pharmaceuticals Limited
Key Trade Statistics of Emcure Pharmaceuticals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.09 |
| Traded Value (₹ Cr.) | 0.86 |
| Total Market Cap (₹ Cr.) | 19,069.16 |
| Free Float Market Cap (₹ Cr.) | 1,663.65 |
| Impact cost | 0.11 |
| Quantity Traded | 432,191.00 |
| Deliverable Quantity | 92,785.00 |
| % of Quantity to Traded | 21.47 |
| Security VaR | 11.32 |
| Index VaR | N/A |
| VaR Margin | 11.32 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 14.82 |
| Face Value | 10 |
Key Price Statistics of Emcure Pharmaceuticals Limited
The 52-week high for Emcure Pharmaceuticals Limited was ₹1,580.00, recorded on 18-Sep-2024. On the other hand, the 52-week low stands at ₹910.95, with the lowest value recorded on 17-Mar-2025.
The upper band for trading is ₹1,100.05, and the lower band is ₹900.05. The price band is 10%.
The stock's daily volatility stands at 1.79, while the annualized volatility is 34.20. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (18-Sep-2024) | 1,580.00 |
| 52 Week Low (17-Mar-2025) | 910.95 |
| Upper Band | 1,100.05 |
| Lower Band | 900.05 |
| Price Band (%) | 10 |
| Daily Volatility | 1.79 |
| Annualised Volatility | 34.20 |
| Tick Size | 0.05 |
Key Securities Statistics of Emcure Pharmaceuticals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 10-Jul-2024 |
| Adjusted P/E | NA |
| Symbol P/E | NA |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Emcure Pharmaceuticals Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Emcure Pharmaceuticals Limited
| Subject | Date |
|---|---|
| Press Release | 10-Mar-2025 |
| General Updates | 26-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 11-Feb-2025 |
| Action(s) initiated or orders passed | 07-Feb-2025 |
| Copy of Newspaper Publication | 07-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 06-Feb-2025 |
| Updates | 06-Feb-2025 |
| Integrated Filing- Financial | 06-Feb-2025 |
Corporate Actions of Emcure Pharmaceuticals Limited
| Face Value | Purpose | Ex-Date | ||
|---|---|---|---|---|
| No corporate actions available | ||||
Board Meetings of Emcure Pharmaceuticals Limited
Financial Results of Emcure Pharmaceuticals Limited
Company Directory of Emcure Pharmaceuticals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | Plot No. P-1 & P-2, IT-BT Park, Phase-II M.I.D.C. Hinjawadi | PUNE |
| N/A | Registered Office | Plot No. P-1 & P-2, IT-BT Park, Phase-II M.I.D.C. Hinjawadi | PUNE |
Insider Trading of Emcure Pharmaceuticals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Emcure Pharmaceuticals Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| No annual reports available | |||
Investor Complaints of Emcure Pharmaceuticals Limited
Event Calendar of Emcure Pharmaceuticals Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Emcure Pharmaceuticals Limited
| Company | Period | Reg.7 | Reg.40 | ||
|---|---|---|---|---|---|
| No Share Transfer data available | |||||
Voting Results of Emcure Pharmaceuticals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 23-DEC-2024 | Postal Ballot | AMENDMENT AND RATIFICATION OF EMCURE - EMPLOYEE STOCK OPTION SCHEME 2013 OF THE COMPANY |
| 23-DEC-2024 | Postal Ballot | RATIFICATION OF EXTENSION OF BENEFITS UNDER EMCURE- EMPLOYEE STOCK OPTION SCHEME 2013 OF THE COMPANY TO THE EMPLOYEES OF A GROUP COMPANY INCLUDING A SUBSIDIARY OR ASSOCIATE COMPANY OF THE COMPANY, IN INDIA OR OUTSIDE INDIA |
FAQs on Emcure Pharmaceuticals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.